7th accp conference on antithrombotic and thrombolytic therapy
Download
1 / 25

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: - PowerPoint PPT Presentation


  • 131 Views
  • Uploaded on

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:. Evidence-Based Guidelines. Grade 1 Recommendations. RCT = randomized controlled trial. Grade 2 Recommendations. RCT = randomized controlled trial. Treatment of Venous Thromboembolic Disease.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about '7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:' - peers


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
7th accp conference on antithrombotic and thrombolytic therapy

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:

Evidence-Based Guidelines


Grade 1 recommendations
Grade 1 Recommendations Therapy:

RCT = randomized controlled trial


Grade 2 recommendations
Grade 2 Recommendations Therapy:

RCT = randomized controlled trial



Initial therapy for acute dvt of the leg
Initial Therapy for Acute DVT of the Leg Therapy:

  • We recommend that patients receive anticoagulants as soon as the diagnosis of DVT is confirmed

  • Interim treatment should be started if suspicion is high and confirmation is delayed








Long term therapy for dvt of the leg continued
Long-term Therapy for DVT of the Leg, continued Therapy:

*Established LMWH regimens for long-term treatment: dalteparin, 200 IU/kg body weight qd for 1 month, then 150 IU/kg qd; or tinzaparin, 175 IU/kg body weight SC qd.






Initial therapy for pe additional recommendations
Initial Therapy for PE: Therapy:Additional Recommendations


Initial therapy for pe additional recommendations continued
Initial Therapy for PE: Therapy:Additional Recommendations, continued



Long term therapy for pe vka therapy continued
Long-Term Therapy for PE: Therapy:VKA Therapy, continued


Long term therapy for pe vka therapy continued1
Long-Term Therapy for PE: Therapy:VKA Therapy, continued